Insider Buying Update for Thursday, December 18: UPXI, ABTC
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Source: NASDAQ.COM
Upexi CEO Investment: Allan Marshall, CEO of Upexi, purchased 150,000 shares of UPXI at $2.07 each, totaling $310,500, and has previously invested $2.3M in the past year at an average of $2.81 per share.
Stock Performance: Upexi's stock is up approximately 4.3% on Thursday following the CEO's recent purchase.
American Bitcoin Purchase: Richard Busch bought $290,500 worth of American Bitcoin, acquiring 175,000 shares at $1.66 each, marking his first purchase in the past year.
Market Reaction: American Bitcoin's stock is down about 2.4% on Thursday despite Busch's investment.
Analyst Views on UPXI
Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.100
Low
6.00
Averages
6.00
High
6.00
Current: 2.100
Low
6.00
Averages
6.00
High
6.00
About UPXI
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
